Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

(2017) John G F Cleland et al.   EUROPEAN HEART JOURNAL

Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction

(2017) Ashish Rastogi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

(2017) Ovidiu Chioncel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure with mid-range ejection fraction: a transition phenotype?

(2017) Antoni Bayés-Genís et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure

(2017) Domingo A. Pascual-Figal et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Heart Failure With Mid-Range (Borderline) Ejection Fraction

(2017) Jeffrey J. Hsu et al.   JACC-Heart Failure

Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

(2017) Ulrik Sartipy et al.   JACC-Heart Failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

(2015) Scott D. Solomon et al.   EUROPEAN HEART JOURNAL